HIV Vaccine Setback: NIAID Halts PAVE 100 Study, But Smaller Trial Planned

The National Institute of Allergy and Infectious Diseases will not move forward with plans for its large-scale Phase IIb HIV vaccine study, though a smaller study is being designed to examine viral response, the center announced July 17